title: Birth cohort screening may help find hepatitis C cases.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Voelker
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006526:Hepatitis C / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008403:Mass Screening / Q000191:economics*; D008875:Middle Aged; D009749:Nutrition Surveys; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011158:Population Growth; D015995:Prevalence; D019057:Quality-Adjusted Life Years; D011994:Recombinant Proteins / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b